Results 221 to 230 of about 130,431 (351)

Sexual Dysfunction and Its Relationship With Hypogonadism and Myelopathy in Male Patients With X‐Linked Adrenoleukodystrophy

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 1, January 2026.
ABSTRACT X‐linked adrenoleukodystrophy (ALD) is a genetic disorder with neurological and endocrine manifestations, including myelopathy and hypergonadotropic hypogonadism. Many patients experience sexual dysfunction but the underlying cause has not been clarified.
Stephanie I. W. van de Stadt   +4 more
wiley   +1 more source

Metabolic control of luteinizing hormone-responsive ovarian steroidogenesis. [PDF]

open access: yesJ Biol Chem
Przygrodzka E   +6 more
europepmc   +1 more source

Free Luteinizing-Hormone Beta-Subunit in Normal Subjects and Patients with Pituitary Adenomas [PDF]

open access: bronze, 1997
Philippe Chanson   +5 more
openalex   +1 more source

Identification and Functional Characterization of a Novel SEMA3A Exon Deletion Variant in Kallmann Syndrome

open access: yesMolecular Genetics &Genomic Medicine, Volume 14, Issue 1, January 2026.
The study identified a novel SEMA3A exons 6–9 deletion variant in Kallmann syndrome that impairs GnRH neuronal migration and alters cell migration, gonad development, and synaptic pathways. The study expands mutation spectrum and offers mechanistic insights for clinical diagnosis of Kallmann syndrome.
Shaolian Zang   +4 more
wiley   +1 more source

Effect of melatonin implants on secretion of luteinizing hormone in intact and castrated rams [PDF]

open access: bronze, 1991
James R. Webster   +4 more
openalex   +1 more source

A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery

open access: yesNano Select, Volume 7, Issue 1, January 2026.
Nanoparticle‐driven nose‐to‐brain drug delivery offers a noninvasive approach to bypass the blood–brain barrier (BBB) and directly modulate reactive astrocytes in CNS disorders. This review highlights biodegradable nanoparticles for astrocyte modulation, enhancing drug bioavailability, sustained release, and neuroinflammation control.
Senamile M. Dlamini   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy